Bredis Healthcare Awarded South Korean Government Grant for Advancing Early Diagnosis of Alzheimer's Disease
22. August 2023 02:45 ET
|
Bredis Healthcare Inc.
Bredis Healthcare secures KRW 1.7 billion grant for advancing Alzheimer’s disease diagnosis from South Korean government’s Deep Tech TIPS programNovel platform has demonstrated detection of...
Checkmate Capital Group Announces Opening of New Flagship Office in Seoul, Korea
12. März 2023 18:00 ET
|
Checkmate Capital
SEOUL, Korea and PASADENA, Calif., March 12, 2023 (GLOBE NEWSWIRE) -- Checkmate Capital Group, LLC (“Checkmate”) is pleased to announce the opening of its flagship corporate offices in Seoul, Korea...
Austrianova Secures Investment from Checkmate Capital
01. März 2023 12:00 ET
|
SG Austria Pte Ltd
SINGAPORE, March 02, 2023 (GLOBE NEWSWIRE) -- SG Austria (“Austrianova”), a leading provider of cell biological products and services, today announced that Checkmate Capital Group (“Checkmate...
Checkmate Capital Group and KAIST Venture Investment Holdings Announce Partnership & Selection as TIPS Operator
26. Juni 2022 23:12 ET
|
Checkmate Capital
LOS ANGELES and SEOUL, South Korea, June 26, 2022 (GLOBE NEWSWIRE) -- A consortium formed by KAIST Venture Investment Holdings and Checkmate Capital Group has been selected as a program operator for...
NeuroSigma Receives FDA Breakthrough Device Designation for Monarch eTNS System®
22. Februar 2022 11:00 ET
|
NeuroSigma, Inc.
LOS ANGELES, Feb. 22, 2022 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a bioelectronic medical device company, today announced FDA Breakthrough Device Designation for its Monarch eTNS System® for...
Ignis Therapeutics Licenses NeuroSigma eTNS Technology for ADHD in a Significant China Licensing Transaction
25. Januar 2022 22:30 ET
|
NeuroSigma, Inc.
Ignis obtains rights to develop and commercialize NeuroSigma’s FDA-approved Monarch eTNS System in ChinaInitial launch of Generation 1.0 device followed by Generation 1.5 device, to deploy in mainland...
NeuroSigma Announces Promotion of Dr. Colin Kealey to President
11. Januar 2022 11:00 ET
|
NeuroSigma, Inc.
LOS ANGELES, Jan. 11, 2022 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a bioelectronic medical device company, today announced the promotion of Dr. Colin Kealey to President. NeuroSigma is the developer...
NeuroSigma Announces a $5 Million Equity Investment by KT Corporation
08. Dezember 2021 05:00 ET
|
NeuroSigma, Inc.
Transaction follows the June 2021 announcement of a strategic digital health partnership between NeuroSigma and KTSignificant investment in NeuroSigma’s digital health and neuro-electronics platform ...
Lynx Biosciences Closes Series Seed Equity Round Led by Checkmate Capital Group
03. November 2021 10:00 ET
|
Lynx Biosciences, Inc.
SAN DIEGO, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Lynx Biosciences, Inc. ("LynxBio®"), a San Diego-based biotechnology company, today announced the successful closing of its Series Seed Preferred Stock...
Checkmate Capital Group Completes Seed Investment in Lactiga, Inc.
02. November 2020 10:00 ET
|
Checkmate Capital
PRINCETON, N.J., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Lactiga, Inc. (“Lactiga”), an award-winning biotherapeutics company developing anti-infective biologics, is pleased to announce the completion of...